What is the best way to reduce birth defects caused by the acne drug isotretinoin?

But the drug can also cause severe birth defects if it is taken by pregnant women. What is the best way to prevent pregnant women from taking the drug, and to prevent women taking it from getting pregnant?

A debate article in PLoS Medicine considers the pros and cons of a new Internet-based system, called iPLEDGE (www.ipledgeprogram.com), which tries to tries to ensure that the drug is dispensed only when there is documentary proof that the patient is not pregnant and is using two forms of birth control.

Citation: Abroms L, Maibach E, Lyon-Daniel K, Feldman SR (2006) What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med 3(11): e483.

– Caption: The iPLEDGE Logo – iPLEDGE is a “comprehensive program to help you get prepared, plan your treatments, and ensure you don't get pregnant during the course of isotretinoin therapy” (https://www.ipledgeprogram.com/). Figure: Covance Inc.

Media Contact

Andrew Hyde alfa

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Study sheds light on cancer cell ‘tug-of-war’

How cancer cells tug against each other determines whether they can migrate elsewhere in the body. Understanding how cancerous cells spread from a primary tumor is important for any number…

Latest generation of self-dissolving stents

Magnesium implants support coronary arteries and keep them open. Constricted coronary arteries harbor dangers: Because the heart is not supplied with blood properly, this can lead to pain, cardiac arrhythmia,…

Stopping blood cancer

The MHH joint project TARGET-MPN is investigating why the disease persists and progresses in malignant bone marrow diseases from the group of myeloproliferative neoplasms despite targeted treatment. Haematopoietic stem cells…

Partners & Sponsors